Stock Traders Buy High Volume of AdaptHealth Call Options (NASDAQ:AHCO)

AdaptHealth Corp. (NASDAQ:AHCO) saw unusually large options trading on Wednesday. Stock investors bought 6,852 call options on the stock. This is an increase of approximately 982% compared to the typical volume of 633 call options.

Wall Street Analysts Forecast Growth

Several brokerages have issued reports on AHCO. Wall Street Zen cut AdaptHealth from a “strong-buy” rating to a “buy” rating in a research report on Saturday, November 8th. Weiss Ratings restated a “hold (c-)” rating on shares of AdaptHealth in a research report on Tuesday. Canaccord Genuity Group increased their price target on shares of AdaptHealth from $14.00 to $15.00 and gave the stock a “buy” rating in a research report on Thursday, November 6th. Finally, Zacks Research cut shares of AdaptHealth from a “hold” rating to a “strong sell” rating in a research note on Friday, September 19th. Five research analysts have rated the stock with a Buy rating, one has issued a Hold rating and one has given a Sell rating to the stock. According to data from MarketBeat, the company has a consensus rating of “Moderate Buy” and a consensus target price of $13.60.

Institutional Trading of AdaptHealth

Institutional investors and hedge funds have recently added to or reduced their stakes in the business. Intech Investment Management LLC raised its position in shares of AdaptHealth by 88.8% during the first quarter. Intech Investment Management LLC now owns 225,452 shares of the company’s stock valued at $2,444,000 after buying an additional 106,035 shares during the last quarter. Russell Investments Group Ltd. grew its stake in AdaptHealth by 96.5% during the first quarter. Russell Investments Group Ltd. now owns 383,464 shares of the company’s stock valued at $4,157,000 after acquiring an additional 188,293 shares in the last quarter. GAMMA Investing LLC increased its holdings in AdaptHealth by 38.7% in the 2nd quarter. GAMMA Investing LLC now owns 10,365 shares of the company’s stock valued at $98,000 after acquiring an additional 2,892 shares during the last quarter. Allianz Asset Management GmbH lifted its stake in AdaptHealth by 127.6% in the 2nd quarter. Allianz Asset Management GmbH now owns 167,279 shares of the company’s stock worth $1,577,000 after purchasing an additional 93,779 shares in the last quarter. Finally, Charles Schwab Investment Management Inc. boosted its holdings in shares of AdaptHealth by 14.3% during the 1st quarter. Charles Schwab Investment Management Inc. now owns 1,301,652 shares of the company’s stock valued at $14,110,000 after purchasing an additional 163,272 shares during the last quarter. Institutional investors own 82.67% of the company’s stock.

AdaptHealth Stock Up 0.4%

Shares of AHCO stock opened at $9.38 on Friday. The company has a debt-to-equity ratio of 1.09, a current ratio of 1.08 and a quick ratio of 0.86. AdaptHealth has a one year low of $7.11 and a one year high of $11.63. The company’s fifty day moving average price is $9.31 and its 200-day moving average price is $9.20. The company has a market capitalization of $1.27 billion, a price-to-earnings ratio of 17.05, a PEG ratio of 1.37 and a beta of 1.77.

AdaptHealth (NASDAQ:AHCO) last issued its quarterly earnings results on Tuesday, November 4th. The company reported $0.19 earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $0.24 by ($0.05). The business had revenue of $820.31 million during the quarter, compared to analysts’ expectations of $799.62 million. AdaptHealth had a return on equity of 4.85% and a net margin of 2.53%.The company’s quarterly revenue was up 1.8% on a year-over-year basis. During the same quarter in the previous year, the company posted $0.15 EPS. Sell-side analysts expect that AdaptHealth will post 0.88 EPS for the current fiscal year.

About AdaptHealth

AdaptHealth Corp., together with its subsidiaries, sells home medical equipment (HME), medical supplies, and home and related services in the United States. The company provides sleep therapy equipment, supplies, and related services, such as CPAP and bi-PAP services to individuals suffering from obstructive sleep apnea; medical devices and supplies, including continuous glucose monitors and insulin pumps for the treatment of diabetes; HME to patients discharged from acute care and other facilities; oxygen and related chronic therapy services in the home; and other HME devices and supplies on behalf of chronically ill patients with wound care, urological, incontinence, ostomy, and nutritional supply needs.